002873 Guiyang Xintian Pharmaceutical
- 11.42
- +0.04+0.35%
Guiyang Xintian Pharmaceutical News
Xintian Pharmaceutical: Explanation of the Board of Directors that this transaction is expected to constitute a major asset restructuring as stipulated in Article 12 of the “Administrative Measures on Major Asset Reorganization of Listed Companies”, but no
Xintian Pharmaceutical: Explanation of the board of directors on the fluctuation of the company's stock price within 20 trading days before the first announcement of this transaction
Xintian Pharmaceutical: Explanation of the Board of Directors that this transaction complies with the provisions of Article 4 of the “Supervisory Guidelines for Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Maj
Xintian Pharmaceutical: Explanation of the board of directors that there are no entities involved in this transaction, section 12 of the “Supervisory Guidelines for Listed Companies No. 7 - Supervision of Abnormal Stock Transactions Related to Major Asset
Xintian Pharmaceutical: Guiyang Xintian Pharmaceutical Co., Ltd. Entity and “Xintian Transfer Bonds” 2023 Annual Tracking Rating Report
Xintian Pharmaceutical: Announcement on not redeeming Xintian Swap Bonds early
Xintian Pharmaceutical: Prompt Announcement on the Possible Satisfaction of Xintian Transfer Bonds to Redemption Requirements
Xintian Pharmaceutical: 2022 Semi-Annual Equity Distribution Implementation Notice
Xintian Pharmaceutical: Announcement on the 2022 Semi-Annual Profit Distribution Plan
Xintian Pharmaceutical: Announcement on not redeeming Xintian Swap Bonds early
Xintian Pharmaceutical: 2021 Equity Distribution Implementation Notice
Xintian Pharmaceutical: 2022 Annual Tracking Rating Report for Subjects and Xintian Transfer Bonds
Xintian Pharmaceutical: Announcement on 2021 Profit Distribution Plan
Xintian Pharmaceutical: Announcement on not redeeming Xintian Swap Bonds early
Xintian Pharmaceutical: Prompt Announcement on the Possible Satisfaction of Xintian Transfer Bonds to Redemption Requirements
Xintian Pharmaceutical: 2021 Interest Payment Announcement on Convertible Corporate Bonds
Xintian Pharmaceutical: Announcement on the 2021 tracking rating results of convertible corporate bonds
Xintian Pharmaceutical: 2020 Interest Payment Announcement on Convertible Corporate Bonds
Xintian Pharmaceutical: Subjects and “Xintianchuan Bonds” 2020 Follow-up Rating Report
Xintian Pharmaceutical: Announcement on 2020 tracking rating results for convertible corporate bonds
Analysis
Price Target
No Data
